156 related articles for article (PubMed ID: 3039021)
21. Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Feb; 48(2):139-47. PubMed ID: 8381374
[TBL] [Abstract][Full Text] [Related]
22. Change in human chorionic gonadotropin in gestational trophoblastic disease observed during the course of chemotherapy.
Huang SC; Hsieh CY; Ouyang PC
J Formos Med Assoc; 1991 Jan; 90(1):53-8. PubMed ID: 1679110
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of combined use of ultrasonography and beta-hCG determination in diagnosis of pelvic lesions of malignant trophoblastic disease].
Fu QZ; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):352-4, 383-4. PubMed ID: 2178083
[TBL] [Abstract][Full Text] [Related]
24. [Actual possibilities of prevention and treatment of trophoblastic disease (author's transl)].
Kudela M; Talas M; Fingerová H
Cesk Gynekol; 1981 Mar; 46(2):108-11. PubMed ID: 6263504
[No Abstract] [Full Text] [Related]
25. [Diagnosis and treatment of trophoblastic uterine tumors].
Kozachenko VP; Toloknov BO; Savinova VF; Grigorova TM
Vopr Onkol; 1982; 28(5):97-103. PubMed ID: 6283736
[TBL] [Abstract][Full Text] [Related]
26. Evolving concepts of molar pregnancy.
Berkowitz RS; Goldstein DP; Bernstein MR
J Reprod Med; 1991 Jan; 36(1):40-4. PubMed ID: 1848899
[TBL] [Abstract][Full Text] [Related]
27. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut.
Kohorn EI
Obstet Gynecol; 1982 Jan; 59(1):78-84. PubMed ID: 6281702
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
Hirashima N
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
[TBL] [Abstract][Full Text] [Related]
29. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
30. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
[TBL] [Abstract][Full Text] [Related]
31. The use of ultrasound in the evaluation of trophoblastic disease and its response to therapy.
Requard CK; Mettler FA
Radiology; 1980 May; 135(2):419-222. PubMed ID: 6245429
[TBL] [Abstract][Full Text] [Related]
32. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
33. Human chorionic gonadotropin (hCG) beta-core fragment is produced by degradation of hCG or free hCG beta in gestational trophoblastic tumors: a possible marker for early detection of persistent postmolar gestational trophoblastic disease.
Okamoto T; Matsuo K; Niu R; Osawa M; Suzuki H
J Endocrinol; 2001 Dec; 171(3):435-43. PubMed ID: 11739009
[TBL] [Abstract][Full Text] [Related]
34. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
Jones WB; Lehr M; Lewis JL
Surg Forum; 1973; 24():563-5. PubMed ID: 4377042
[No Abstract] [Full Text] [Related]
35. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
36. The hCG assay in the treatment of trophoblastic disease.
Pattillo RA; Hussa RO
J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
[TBL] [Abstract][Full Text] [Related]
37. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
38. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
Thomas CM; Kerkmeijer LG; Ariaens HJ; van der Steen RC; Massuger LF; Sweep FC
Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
[TBL] [Abstract][Full Text] [Related]
39. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide].
Shimizu T; Matsuura S; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct; 35(10):1759-66. PubMed ID: 6195275
[TBL] [Abstract][Full Text] [Related]
40. Cancer chemotherapy based on the measurement of a tumor specific antigen.
Goldstein DP; Nudemberg F; Shirley RL
Surg Forum; 1971; 22():390-2. PubMed ID: 4330603
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
